Brief: NLS Pharma Says Co and Kadimastem Announce Binding Term Sheet to Merge
July 29 (Reuters) - NLS Pharmaceutics AG NLSP.O :
* NLS PHARMACEUTICS AG: NLS PHARMACEUTICS AND KADIMASTEM
ANNOUNCE
BINDING TERM SHEET TO MERGE
* NLS PHARMACEUTICS AND KADIMASTEM ANNOUNCE BINDING TERM
SHEET TO
MERGE
* NLS PHARMACEUTICS AG: KADIMASTEM'S SHAREHOLDERS WILL
ACQUIRE 85%
INTEREST IN CO
* NLS PHARMACEUTICS AG: COMBINED CO TO OPERATE UNDER NAME
KADIMASTEM AND BE TRADED ON NASDAQ
Source text for Eikon: ID:
Further company coverage: NLSP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NewcelX AG
See all newsBrief: Newcelx Announces Pricing Of $1.4 Million Equity Financing At 20% Premium Pricing
Brief: Newcelx Submits Pre-IND Package To FDA For NCEL-101 For Treatment Of Type 1 Diabetes
Brief: Newcelx Updates Corporate Presentation To Highlight Type 1 Diabetes Flagship Program
U.S. STOCKS ON THE MOVE-Eli Lilly, Space stocks, Anixa Biosciences
U.S. STOCKS ON THE MOVE-Intel, Tempus AI, Boeing